PE-backed Emmes buys Orphan Research
Emmes, a portfolio company of Behrman Capital, has acquired Orphan Reach, a clinical research organization focused on clinical research related to rare diseases.
12 May 2021•4 mins read
Emmes, a portfolio company of Behrman Capital, has acquired Orphan Reach, a clinical research organization focused on clinical research related to rare diseases.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
20 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
20 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
20 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
20 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
21 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
21 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
23 hours ago · 3 mins read
